| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $669.7M | — | -4.5% |
| Cost of Revenue | $448.8M | — | -3.5% |
| Gross Profit | $220.9M | — | -6.4% |
| R&D Expense | $31.6M | — | -4.6% |
| SG&A Expense | $46.0M | — | +7.1% |
| Operating Income | $143.2M | — | -10.4% |
| Interest Expense | $8.8M | — | -18.0% |
| Pre-tax Income | $151.7M | — | -7.6% |
| Income Tax | $33.6M | — | -12.0% |
| Net Income | $118.1M | — | -6.3% |
| EPS (Basic) | $12.62 | — | -4.8% |
| EPS (Diluted) | $12.62 | — | -4.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $73.2M | -5.7% | -38.1% |
| Accounts Receivable | $438.4M | +3.9% | -5.4% |
| Inventory | $495.0M | -1.5% | +1.1% |
| Current Assets | $1.06B | +0.5% | -5.2% |
| Total Assets | $3.50B | +0.3% | +8.4% |
| Current Liabilities | $417.3M | -0.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $124.0M | — | +3.1% |
| Capital Expenditures | $24.4M | — | +87.1% |
| Investing Cash Flow | -$23.2M | — | -78.4% |
| Financing Cash Flow | -$100.9M | — | -47.3% |
| Free Cash Flow | $99.7M | — | -7.1% |
| +5.3% |
| Long-term Debt | $939.6M | +6.4% | -5.1% |
| Total Liabilities | $1.77B | +3.4% | +3.4% |
| Stockholders' Equity | $1.73B | -2.6% | +14.0% |